Search clinical trials for: FLT3 TKD
Total 166 results
-
Eli Lilly and CompanyCompletedAxial SpondyloarthritisUnited States, Puerto Rico, Russian Federation, Mexico, Poland, Argentina, Austria, Brazil, Canada, Czechia, Finland, Germany, Japan, Korea, Republic of, Netherlands, Romania
-
Arog Pharmaceuticals, Inc.AvailableFLT3-ITD Mutation | FLT3/TKD Mutation | PDGFR-Alpha D842V | PDGFRA Gene AmplificationItaly
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed
-
Istituto Scientifico Romagnolo per lo Studio e...UnknownAML | FLT3-ITD Mutation | FLT3-TKD MutationItaly
-
The First Affiliated Hospital of Soochow UniversityThe First Affiliated Hospital with Nanjing Medical University; The Affiliated... and other collaboratorsRecruitingAcute Myeloid LeukemiaChina
-
PrECOG, LLC.Astellas Pharma IncActive, not recruitingAcute Myeloid LeukemiaUnited States
-
The University of Hong KongUnknownAML | FLT3-ITD MutationHong Kong
-
Arog Pharmaceuticals, Inc.CompletedPhase II Study of Crenolanib in Subjects With Relapsed/Refractory AML With FLT3 Activating MutationsRelapsed or Refractory Acute Myeloid Leukemia With FLT3 Activating MutationsUnited States
-
Aptose Biosciences Inc.Active, not recruitingAcute Myeloid Leukemia | Myelodysplastic SyndromesUnited States
-
Arog Pharmaceuticals, Inc.CompletedAcute Myeloid Leukemia With FLT3 Activating Mutations That Has Relapsed or Been Refractory After One or More Prior TherapiesUnited States
-
Universitätsklinikum Hamburg-EppendorfCompletedAcute Myeloid LeukemiaGermany
-
Biomea Fusion Inc.RecruitingAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Acute Mixed-Phenotype LeukemiaUnited States
-
Spirita Oncology, LLCTerminatedAML | MDS | CMMLUnited States
-
Novartis PharmaceuticalsNo longer availableAcute Myeloid Leukemia (AML) With | FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD)United States
-
French Innovative Leukemia OrganisationAcute Leukemia French AssociationRecruitingAML, Adult | Relapsed Adult AML | Refractory AML | FLT3-TKD Mutation | FLT3-ITDFrance
-
Senti BiosciencesRecruitingAML/MDS | CD33 Expressing Hematological Malignancies | FLT3 Expressing Hematological MalignanciesUnited States, Australia
-
Novartis PharmaceuticalsCompletedAcute Myeloid LeukemiaItaly, Croatia, Estonia, Czechia, France, Spain, Sweden, Bulgaria, Lithuania, Serbia, Hungary, Finland, Norway, Romania, Slovakia
-
Astellas Pharma Global Development, Inc.CompletedAcute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) MutationUnited States
-
Daiichi Sankyo, Inc.CompletedAcute Myeloid LeukemiaUnited States, Spain, Netherlands, Canada, France, Germany, United Kingdom, Italy, Poland
-
Novartis PharmaceuticalsCompletedTumor Pathway Activations Inhibited by DovitinibUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); Southwest Oncology Group; Cancer and Leukemia...Completed
-
French Innovative Leukemia OrganisationAcute Leukemia French AssociationCompletedRelapsed Adult AML | Refractory AML | FLT3-TKD Mutation | FLT3-ITDFrance
-
SCRI Development Innovations, LLCTerminatedLeukemia, Myeloid, AcuteUnited States
-
Astellas Pharma Global Development, Inc.RecruitingAcute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem Duplication (ITD)United States, Canada, Germany, Italy, Spain, United Kingdom, France
-
Astellas Pharma Global Development, Inc.Active, not recruitingAcute Myeloid Leukemia (AML) | Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) MutationUnited States, Japan, Taiwan, Spain, Australia, Belgium, Canada, France, Germany, Italy, Korea, Republic of, Poland, United Kingdom
-
Ayman H QasrawiAstellas Pharma IncWithdrawn
-
Novartis PharmaceuticalsCompletedAcute Myeloid LeukemiaJapan, Taiwan, Hong Kong, Thailand, Korea, Republic of, Russian Federation, Vietnam
-
Erasca, Inc.WithdrawnAcute Myeloid LeukemiaUnited States
-
Daiichi Sankyo, Inc.CompletedAcute Myeloid Leukemia | Leukemia | AML | Myelodysplastic Syndrome | MDSUnited States, Georgia
-
Taipei Medical University WanFang HospitalUnknownAcute Myeloid LeukemiaTaiwan
-
National Cancer Institute (NCI)CompletedKidney Cancer | Melanoma (Skin)United States
-
Duke UniversityNational Cancer Institute (NCI)CompletedColorectal Cancer | Metastatic CancerUnited States
-
University Hospital Inselspital, BerneTerminatedAML, AdultSwitzerland
-
Göteborg UniversityCompleted
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.RecruitingFLT3-positive Relapsed/Refractory Acute Myeloid LeukemiaChina
-
Albert Einstein College of MedicineCelldex TherapeuticsTerminatedLung Cancer | Non Small Cell Lung CancerUnited States
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma US, Inc.RecruitingAcute Myeloid Leukemia (AML)United States
-
Arog Pharmaceuticals, Inc.RecruitingNewly Diagnosed FLT3 Mutated AMLUnited States
-
The University of Hong KongCompletedAML | FLT3-ITD MutationHong Kong
-
Zhejiang ACEA Pharmaceutical Co. Ltd.Recruiting
-
The First Affiliated Hospital of Soochow UniversityUnknown
-
Princess Maxima Center for Pediatric OncologyDaiichi SankyoRecruitingAcute Myeloid Leukemia in ChildrenNetherlands
-
Albert Einstein College of MedicineCelldex TherapeuticsCompletedNon-small Cell Lung Cancer (NSCLC)United States
-
Telios Pharma, Inc.Kartos Therapeutics, Inc.Active, not recruitingAcute Myeloid LeukemiaUnited States, Korea, Republic of, Spain, France, Austria, Australia, Germany, Italy
-
Robert ZeiserCompleted
-
Gruppo Italiano Malattie EMatologiche dell'AdultoRecruitingAcute Myeloid Leukemia With FLT3/ITD MutationItaly
-
National Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IV Melanoma | Stage IV Renal Cell Cancer | Recurrent Renal Cell CancerUnited States
-
Northwestern UniversityCompletedLymphoma | Leukemia | Breast Cancer | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative DiseasesUnited States
-
Daiichi Sankyo, Inc.No longer availableAcute Myeloid Leukemia With Gene Mutations
-
National Cancer Institute (NCI)CompletedMelanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Ocular Melanoma | Stage IIIC Cutaneous Melanoma AJCC v7 | Melanoma of Unknown Primary | Cutaneous Melanoma | Mucosal Melanoma | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7 | Stage... and other conditionsUnited States